4//SEC Filing
REGENERON PHARMACEUTICALS INC 4
Accession 0001237899-15-000052
$REGNCIK 0000872589operating
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:06 PM ET
Size
8.0 KB
Accession
0001237899-15-000052
Insider Transaction Report
Form 4
BAKER CHARLES A
Director
Transactions
- Sale
Common Stock
2015-09-17$550.00/sh−5,000$2,750,000→ 9,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-09-17−5,000→ 5,000 totalExercise: $18.61Exp: 2019-01-02→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2015-09-17$18.61/sh+5,000$93,050→ 14,000 total
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS INC
CIK 0000872589
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000872589
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:06 PM ET
- Size
- 8.0 KB